[86] reported that RG7834, a novel oral HBV gene expression inhibitor, could reduce the levels of viral proteins and reduced viremia. RG7834 is a little-molecule compound belonging towards the dihydroquinolizinones chemical course comparable to RNAi but by another system.Consenil Sulfhydryl alkyl